Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025. THIRD QUARTER FINANCIAL HIGHLIGHTS: REVENUE OF $706.3 MILLION, INCREASED 29.9%, OR 28.2% IN CONSTANT CURRENCY1, AND EXCEEDED THE HIGH END OF THE COMPANY'S GUIDANCE RANGE OF 22% - 25% AT CONSTANT CURRENCY RATES TOTAL OMNIPOD REVENUE.

INSULET REPORTS THIRD QUARTER 2025 RESULTS

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED ITS NEW CAMPAIGN, THE DAY DIABETES SHOWED UP TO WORK, IN HONOR OF DIABETES AWARENESS MONTH, WHICH STARTS NOVEMBER 1. NEARLY 590 MILLION PEOPLE WORLDWIDE LIVE WITH DIABETES1, AND APPROXIMATELY 70 PERCENT ARE OF WORKING AGE. YET TOO OFTEN THEIR EXPERIENCE AT WORK IS SHAPED BY MISUNDERSTANDING, FEAR.

INSULET CHAMPIONS WORKPLACE INCLUSION FOR PEOPLE WITH DIABETES WITH NEW DATA AND TOOLS RELEASED FOR DIABETES AWARENESS MONTH

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED THE APPOINTMENT OF ROBERT (ROBBIE) L. HUFFINES, A FORMER GLOBAL CHAIR OF INVESTMENT BANKING AT JP MORGAN CHASE & CO., TO THE COMPANY'S BOARD OF DIRECTORS, EFFECTIVE OCTOBER 31, 2025. MR. HUFFINES JOINS THE BOARD AS AN INDEPENDENT DIRECTOR AND WILL SERVE ON THE BOARD'S AUDIT COMMITTEE. WE ARE.

INSULET ANNOUNCES APPOINTMENT OF ROBERT L. HUFFINES TO ITS BOARD OF DIRECTORS

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, WILL HOST AN INVESTOR DAY AT THE COMPANY'S ACTON, MASSACHUSETTS HEADQUARTERS ON THURSDAY, NOVEMBER 20, 2025. THE INVESTOR DAY WILL INCLUDE PRESENTATIONS FROM THE MANAGEMENT TEAM HIGHLIGHTING THE COMPANY'S LONGER-TERM STRATEGIC PRIORITIES, INCLUDING MARKET OPPORTUNITIES, INNOVATION ROADMAP, AS WELL AS ITS LONGER-TER.

INSULET TO HOST INVESTOR DAY ON NOVEMBER 20, 2025

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, AND PANTONE, THE GLOBAL AUTHORITY ON COLOR AND PROVIDER OF PROFESSIONAL COLOR STANDARDS FOR THE DESIGN INDUSTRIES, TODAY ANNOUNCED THE CREATION OF OMNIPOD MANGO, A BRIGHT AND JOYFUL TROPICAL ORANGE YELLOW. OMNIPOD MANGO WAS UNIQUELY SELECTED TO CELEBRATE THE RADIANCE OF THE DIABETES COMMUNITY AND SYMBOLIZES INSULE.

INSULET AND PANTONE PARTNER TO LAUNCH OMNIPOD MANGO IN VIBRANT NEW PALETTE

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED THAT FLAVIA PEASE WILL SUCCEED ANA MARIA CHADWICK AS EXECUTIVE VICE PRESIDENT, CHIEF FINANCIAL OFFICER, EFFECTIVE SEPTEMBER 30, 2025. MS. CHADWICK WILL BECOME A SENIOR ADVISOR TO INSULET TO ENSURE A SMOOTH TRANSITION. I WANT TO PERSONALLY THANK ANA, WHO HAS PROVIDED STEADY AND THOUGHTFUL LEADER.

INSULET ANNOUNCES CFO TRANSITION

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED THE APPOINTMENT OF ERIC BENJAMIN TO CHIEF OPERATING OFFICER EFFECTIVE IMMEDIATELY. THE COMPANY ALSO ANNOUNCED THE APPOINTMENT OF MANOJ RAGHUNANDANAN AS CHIEF GROWTH OFFICER. IN THIS EXPANDED ROLE, MR. BENJAMIN WILL LEAD INSULET'S END-TO-END GROWTH AND INNOVATION ENGINE, SETTING STRATEGY AND GUIDING.

INSULET ELEVATES ERIC BENJAMIN TO CHIEF OPERATING OFFICER

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED THAT MANAGEMENT WILL PRESENT AT THE UPCOMING INVESTOR CONFERENCES (ALL EASTERN TIME): WELLS FARGO 2025 HEALTHCARE CONFERENCE IN BOSTON ON SEPTEMBER 4 AT 3:00 P.M. BAIRD 2025 GLOBAL HEALTHCARE CONFERENCE IN NEW YORK CITY ON SEPTEMBER 9 AT 12:15 P.M. BERNSTEIN INSIGHTS: HEALTHCARE LEADERS & DISRUPTORS FORUM IN NEW YORK CI.

INSULET TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2025. SECOND QUARTER FINANCIAL HIGHLIGHTS: REVENUE OF $649.1 MILLION, UP 32.9%, OR 31.3% IN CONSTANT CURRENCY, EXCEEDS THE HIGH END OF THE COMPANY'S GUIDANCE RANGE OF 26.0% IN CONSTANT CURRENCY TOTAL OMNIPOD REVENUE OF $639.0 MILLION, UP 33.0%, O.

INSULET REPORTS SECOND QUARTER 2025 REVENUE INCREASE OF 32.9% YEAR-OVER-YEAR (31.3% CONSTANT CURRENCY1)

ACTON, MASS.--(BUSINESS WIRE)--INSULET CORPORATION (NASDAQ: PODD) (INSULET OR THE COMPANY), THE GLOBAL LEADER IN TUBELESS INSULIN PUMP TECHNOLOGY WITH ITS OMNIPOD BRAND OF PRODUCTS, TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2025 ON AUGUST 7, 2025, BEFORE THE OPENING OF THE FINANCIAL MARKETS. IN CONNECTION WITH THE RELEASE, MANAGEMENT WILL HOST A CONFERENCE CALL THAT DAY AT 8:00 A.M. (EASTERN TIME). THE LINK TO THE LIVE CALL WILL BE AVAILABLE ON THE INVESTOR REL.

INSULET TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 7, 2025

ACTON, MASS.--(BUSINESS WIRE)--INSULET TO SHARE ADDITIONAL EVIDENCE DEMONSTRATING THE IMPACT OF OMNIPOD 5 ON IMPROVED HEALTH OUTCOMES AT THE AMERICAN DIABETES ASSOCIATION CONFERENCE.

INSULET TO SHARE ADDITIONAL EVIDENCE DEMONSTRATING THE IMPACT OF OMNIPOD 5 ON IMPROVED HEALTH OUTCOMES AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS

Insulet Corporation

PODD

Price

PODD financial data will be collected soon.

Press Releases

Insulet Corporation

PODD.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

PODD financial data will be collected soon.

Press Releases

PODD